Dr. Kimberly S. Strickland
Claim this profileNovant Health Presbyterian Medical Center
Studies Breast Cancer
Studies Cancer
5 reported clinical trials
17 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
ER negative
2Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Kimberly S. Strickland is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
More about Kimberly S. Strickland
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Kimberly S. Strickland has experience with
- Paclitaxel
- Trastuzumab
- Pertuzumab
- Trastuzumab Emtansine
- Tucatinib
- Nivolumab
Breakdown of trials Kimberly S. Strickland has run
Breast Cancer
Esophageal Adenocarcinoma
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kimberly S. Strickland specialize in?
Kimberly S. Strickland focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Kimberly S. Strickland currently recruiting for clinical trials?
Yes, Kimberly S. Strickland is currently recruiting for 4 clinical trials in Charlotte North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Kimberly S. Strickland has studied deeply?
Yes, Kimberly S. Strickland has studied treatments such as Paclitaxel, Trastuzumab, Pertuzumab.
What is the best way to schedule an appointment with Kimberly S. Strickland?
Apply for one of the trials that Kimberly S. Strickland is conducting.
What is the office address of Kimberly S. Strickland?
The office of Kimberly S. Strickland is located at: Novant Health Presbyterian Medical Center, Charlotte, North Carolina 28204 United States. This is the address for their practice at the Novant Health Presbyterian Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.